Pune, July 22, 2022 (GLOBE NEWSWIRE) — The Global bioreactor market the size was fixed at ~US$2.56 billion in 2021. The market should align ~US$9.75 billion by 2030to grow to a ~16.0% CAGR between the forecast period. All information is presented in the latest report published by Growth Plus Reports. Report title “Bioreactors Market by type of material (glass, stainless steel and single-use), by use (laboratory scale production, pilot scale production and large scale production), by end user (pharmaceutical and biopharmaceutical manufacturers, organization of contract research, university and research institutes and others) – Global Outlook and Forecast 2022-2030”
Download exclusive sample report @ https://growthplusreports.com/inquiry/request-sample/bioreactor-market/7729
In the pharmaceutical industry, the growing demand for therapeutic drugs will drive the market revenue. Due to the high prevalence of cancer, there is an increasing demand for monoclonal antibodies (mAb). Additionally, continuous advancements in bioprocessing equipment, widespread adoption of advanced technologies, and growing demand for single-use bioreactors will drive the growth of the market.
The coronavirus infection has recently affected millions of people around the world. The number of victims worldwide has increased due to community transmission in some countries. Biopharmaceutical and biotech companies have been intensely focused on researching and developing the COVID-19 vaccine. The coronavirus outbreak has driven unprecedented demand for bioreactors, with companies investing heavily in research and development as well as mass production.
Excerpts from ‘By one-time segmentation’
Based on material type, the global bioreactor market has been segmented into
- Stainless steel
During the forecast period, the single-use segment is expected to dominate the global bioreactor market. Due to increased demand for biologic drugs, government initiatives to further develop the pharmaceutical sector, and progress in vaccine research and development activities. The benefits of single-use bioreactors, such as reduced cleaning and sterilization requirements, reduced risk of cross-contamination, and better control of aseptic conditions, are attributed to the steady revenue growth of this segment. By reducing the complexity of automation, single-use bioreactors improve the quality of the final product.
However, due to an increase in demand for monoclonal antibiotics, technological advancements for advanced bioreactors, and increased funding for biotech segments. For example, in February 2020, according to the American Pharmaceutical Review, 71.2% of industries use single-use bioreactors in process development, and more than 55% use single-use sampling systems in clinical production. or commercial. Additionally, product innovation is a key trend gaining momentum in the single-use bioreactor market. Technological advancements and growing popularity of mobile gaming technology are also fueling the market demand. The major players in the market are focusing on launching innovative products to drive the growth of the market. For example, in March 2020, Sartorius, a Germany-based biopharmaceutical company, launched BIOSTAT STR Generation 3 with BIOBRAIN, making biopharmaceutical development and production faster, simpler, and safer. This robust industrial platform includes hardware, software and consumables for single-use process development and commercial biomanufacturing.
Ask here for more customization study @ https://growthplusreports.com/inquiry/customization/bioreactor-market/7729
Excerpts from ‘Segmentation by region’
Based on region, the global bioreactor market has been segmented into
- North America
- Asia Pacific
- Rest of the world (right-of-way)
North America held the largest revenue share in the global bioreactor market and is expected to grow at a rapid rate during the forecast period.
Rising number of biological manufacturing facilities and investments in this region is driving the growth of the market. Furthermore, active support from regional governments to boost the production of biologics by providing funds for life science R&D will contribute to the market revenue growth during the forecast period. Industry players expanding in emerging economies for reasons of cost reduction and establishment of new manufacturing units will drive the growth of the bioreactors market in the region.
The market in Europe is expected to grow at a rapid rate over the forecast period, owing to increasing research investments and industrial capacity of biopharmaceutical companies in the region, as well as increasing collaborations between industry and academics to carry out research and development activities. The European Commission (EC) has proposed a new patient-centred pharmaceutical strategy for member countries, extending to ensure the quality and safety of medicines. Similarly, under the new European Health Emergency Response Authority, the EC is encouraging investment to coordinate the research, development and manufacture of new antibiotics. This is expected to increase the demand for bioreactors used to prepare vaccines and drugs, as well as drive revenue growth in the market in the region.
Excerpts from “Competitive Landscape”
The global bioreactors market is moderately consolidated, with a few key players operating at the global and regional levels. Strategic alliances are formed by key players in order to expand their respective portfolios and gain a firm foothold in the global market.
Some of the major players operating in the global bioreactors market are
- BBI Biotech GmbH
- Danaher Corporation
- Bioengineering SA
- Eppendorf AG
- Sartorius AG
- HT info
- Merck KGAA
- ThermoFisher Scientific, Inc.
- Solaris Biotech Solutions
Report Scope and Segmentation:
|Market size in 2021||~$2.56 billion|
|Revenue forecasts in 2030||~$9.75 billion|
|Rate of growth||CAGR of ~16.0% from 2022 to 2030|
|Base year for the estimate||2021|
|Segments Covered||By type of material, by use, by end user|
|Regional scope||North America, Europe, Asia-Pacific and Rest of the World (ROW)|
- Market ecosystem
- Schedule under study
- Historical years – 2020
- Base year – 2021
- Planned years – 2022 to 2030
- Currency used in the report
- RESEARCH METHODOLOGY
- Research approach
- Data collection methodology
- Information source
- Secondary sources
- Primary sources
- Market estimation approach
- From bottom to top
- From top to bottom
- Market Forecast Model
- Limits and assumptions
- PREMIUM OVERVIEW
- Current market trend (COVID-19 outlook)
- Key players and competitive positioning (2021)
- MARKET DYNAMICS
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Fueled by free analyst hours and expert interviews with every report
- Comprehensive quantitative and qualitative information at segment and sub-segment level
- Trends and perspectives of the impact of Covid 19
- Granular information at global/regional/country level
- In-depth insights into market dynamics (drivers, restraints, opportunities) and business environment
- Global coverage of the competitive landscape
- Winning imperatives
- Comprehensive coverage of “strategic developments” recorded by major market players
- Distributor Landscape Assessment
- Pricing Information
- Customer evaluation
- Analysis of investments and initiatives
- ‘Company Profile’ of key players
Talk to our expert: https://growthplusreports.com/inquiry/speak-analyst/bioreactor-market/7729
Growth+Reports is part of GRG Health, a global healthcare knowledge services company. We are proud members of the EPhMRA (European Pharmaceutical Marketing Research Association).
The Growth+ portfolio of services leverages our core capabilities in secondary and primary research, market modeling and forecasting, benchmarking, analysis and strategy formulation to help clients create scalable and game-changing solutions. that prepare them for future growth and success.
We have been recognized by the prestigious CEO Magazine as “2020’s Most Innovative Healthcare Market Research Company”.